drugset / Trial / NCT00841919

Insulin Therapy in the Hospital Comparing Two Protocols

NCT00841919 ↗

Phase 4 Completed 60 enrolled Cook County Health Eli Lilly and Company · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if by using insulin analog (Glargine and lispro insulin) with an insulin pen the investigators are able to obtain a higher rate of correct timing of insulin and food administration as when compared to the usual therapy (insulin NPH and regular) with syringes.

Timeline

Start
2006-12
Primary completion
2009-03
Completion
2009-06

Outcome

Met primary endpoint

paper insulin was given within target time was significantly higher in the intervention group as a whole (88.9% vs 70.1%, P<.001) PMID 21454236 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Lispro Protein / enzyme biologic — —
Comparator NPH insulin Protein / enzyme biologic — —
Subject insulin glargine Protein / enzyme biologic — —
Comparator regular insulin Protein / enzyme biologic — —